Copyright
©The Author(s) 2025.
World J Psychiatry. Jan 19, 2025; 15(1): 101182
Published online Jan 19, 2025. doi: 10.5498/wjp.v15.i1.101182
Published online Jan 19, 2025. doi: 10.5498/wjp.v15.i1.101182
Group | VEGF (ng/L) | NOS (ng/L) | ET-1 (U/mL) | |||
Before treatment | After 8 weeks of treatment | Before treatment | After 8 weeks of treatment | Before treatment | After 8 weeks of treatment | |
Observation group | 298.54 ± 35.25 | 418.84 ± 42.15a | 24.84 ± 6.15 | 37.98 ± 6.41a | 91.58 ± 7.54 | 50.65 ± 5.48a |
Control group | 297.73 ± 34.91 | 315.24 ± 39.58b | 24.75 ± 6.48 | 25.44 ± 6.05b | 92.05 ± 8.01 | 64.25 ± 6.51b |
t value | 0.110 | 12.019 | 0.068 | 9.544 | 0.287 | 10.721 |
P value | > 0.05 | < 0.05 | > 0.05 | < 0.05 | > 0.05 | < 0.05 |
- Citation: Yang KJ, Huang JJ, Xuan CX. Association of stent thrombectomy and conventional treatment with neuroprotection, complications, anxiety, and depression in acute ischemic stroke patients. World J Psychiatry 2025; 15(1): 101182
- URL: https://www.wjgnet.com/2220-3206/full/v15/i1/101182.htm
- DOI: https://dx.doi.org/10.5498/wjp.v15.i1.101182